AU1598297A - Method of inactivation of ras subfamily proteins and agents therefor - Google Patents
Method of inactivation of ras subfamily proteins and agents thereforInfo
- Publication number
- AU1598297A AU1598297A AU15982/97A AU1598297A AU1598297A AU 1598297 A AU1598297 A AU 1598297A AU 15982/97 A AU15982/97 A AU 15982/97A AU 1598297 A AU1598297 A AU 1598297A AU 1598297 A AU1598297 A AU 1598297A
- Authority
- AU
- Australia
- Prior art keywords
- inactivation
- ras
- agents therefor
- ras subfamily
- subfamily proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6829—Bacterial toxins, e.g. diphteria toxins or Pseudomonas exotoxin A
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Electrotherapy Devices (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96101469 | 1996-02-02 | ||
EP96101469 | 1996-02-02 | ||
PCT/EP1997/000426 WO1997027871A1 (fr) | 1996-02-02 | 1997-01-31 | Procede d'inactivation de proteines de la sous-famille ras et agents utiles a cet effet |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1598297A true AU1598297A (en) | 1997-08-22 |
Family
ID=8222454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU15982/97A Abandoned AU1598297A (en) | 1996-02-02 | 1997-01-31 | Method of inactivation of ras subfamily proteins and agents therefor |
Country Status (9)
Country | Link |
---|---|
US (1) | US6849715B2 (fr) |
EP (1) | EP0877622B1 (fr) |
AT (1) | ATE273712T1 (fr) |
AU (1) | AU1598297A (fr) |
DE (1) | DE69730313T2 (fr) |
DK (1) | DK0877622T3 (fr) |
ES (1) | ES2227667T3 (fr) |
PT (1) | PT877622E (fr) |
WO (1) | WO1997027871A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005039491A2 (fr) * | 2003-10-22 | 2005-05-06 | The John Hopkins University | Therapie bacteriolytique combinee amelioree certaine pour le traitement de tumeurs |
WO2005039492A2 (fr) | 2003-10-22 | 2005-05-06 | The John Hopkins University | Therapie bacteriolytique combinee amelioree pour le traitement de tumeurs |
US10829752B2 (en) | 2014-08-01 | 2020-11-10 | Northwestern University | Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2694296B1 (fr) * | 1992-07-30 | 1994-09-02 | Rhone Poulenc Rorer Sa | Peptides inhibant l'activité des protéines ras, préparation et utilisation. |
PT692974E (pt) * | 1993-03-29 | 2003-09-30 | Pfizer | Vacinas clostridiais com multiplos componentes usando adjuvantes de saponina |
-
1997
- 1997-01-31 DK DK97902278T patent/DK0877622T3/da active
- 1997-01-31 PT PT97902278T patent/PT877622E/pt unknown
- 1997-01-31 EP EP97902278A patent/EP0877622B1/fr not_active Expired - Lifetime
- 1997-01-31 DE DE69730313T patent/DE69730313T2/de not_active Expired - Lifetime
- 1997-01-31 ES ES97902278T patent/ES2227667T3/es not_active Expired - Lifetime
- 1997-01-31 AT AT97902278T patent/ATE273712T1/de not_active IP Right Cessation
- 1997-01-31 WO PCT/EP1997/000426 patent/WO1997027871A1/fr active IP Right Grant
- 1997-01-31 AU AU15982/97A patent/AU1598297A/en not_active Abandoned
-
1998
- 1998-07-31 US US09/126,816 patent/US6849715B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE273712T1 (de) | 2004-09-15 |
EP0877622A1 (fr) | 1998-11-18 |
US6849715B2 (en) | 2005-02-01 |
DK0877622T3 (da) | 2004-12-20 |
WO1997027871A1 (fr) | 1997-08-07 |
DE69730313T2 (de) | 2005-09-01 |
US20030103987A1 (en) | 2003-06-05 |
PT877622E (pt) | 2005-01-31 |
ES2227667T3 (es) | 2005-04-01 |
EP0877622B1 (fr) | 2004-08-18 |
DE69730313D1 (de) | 2004-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Violand et al. | Mechanism of the urokinase-catalyzed activation of human plasminogen. | |
Mannervik et al. | Relative contributions of thioltransferase-and thioredoxin-dependent systems in reduction of low-molecular-mass and protein disulphides | |
TR199701705T1 (xx) | Trigliserid ya�lar�n i�lenmesinde hareketsiz enzim ve kullan�m�. | |
NZ330860A (en) | Method of inhibiting photoaging of skin | |
ATE186834T1 (de) | Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut | |
DE69328550D1 (de) | Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln | |
WO1992019700A3 (fr) | Procede continu de desulfuration biocatalytique de molecules heterocycliques porteuses de soufre | |
DE69727142D1 (de) | Verwendung eines bpi proteinproduktes als antithrombotisches mittel | |
DE50014190D1 (de) | Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten | |
CA2238879A1 (fr) | Applications therapeutiques pour l'anticorps monoclonal 5c8 anti-t-bam (anti-cd40-l) | |
ATE188256T1 (de) | Oberflächenlokalisierte expression von enzymen in gengesteuerter prodrugtherapie | |
Takahashi-Nakamura et al. | Purification and characterization of an inhibitor of calcium-activated neutral protease from rabbit skeletal muscle | |
WO1997040072A3 (fr) | Proteines adam et leur utilisation | |
AU6256996A (en) | Use of vitamin D4 derivatives for treating skin disorders | |
NZ505742A (en) | Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses | |
BR9808606A (pt) | Materiais e métodos para tratamento de doenças com ribozimas | |
DE60008915D1 (de) | Konstrukte zur verabreichung von therapeutischen wirkstoffen an die neuronzellen | |
AU6178198A (en) | Method of treating a tumor | |
ATE213630T1 (de) | Verwendung vonsisovaleramid als mildes anxiolytisches und sedatives mittel | |
AU1598297A (en) | Method of inactivation of ras subfamily proteins and agents therefor | |
WO1997030714A3 (fr) | Composition pharmaceutique a administration locale contenant de l'heparine | |
ATE234614T1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
Lee et al. | Isolation and purification of rabbit adrenal norephinephrine N-methyl transferase isozymes | |
AU4481696A (en) | Process for improving the functioning and catalytic activity of electrodes and catalytic substances used in an electrochemical or electrocatalytic process | |
ATE127839T1 (de) | Varianten des gewebeplasminogenaktivators mit vermindertem abbau. |